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Introduction
• Background:
– PD is a high-risk, complex abdominal procedure with high rates of peri-
operative morbidity. Prolonged hospital stay increases the risk of 
debility and increases cost to patients
– Whipple Accelerated Recovery Pathway (WARP)- developed for highly 
selected patients 
• Limited comorbidities
• Firm pancreas texture 
• Resectable disease 
– Randomized Control Trial published in 2018 by Yeo et al., showed 
WARP can safely decrease hospital length of stay (LOS) and time to 
adjuvant therapy (TTAT) in selected PD patients without increasing 
readmission risk/rates as compared to the traditional control pathway 
Introduction
• Rationale: 
– If WARP was so successful for low-risk patients, how well 
would higher-risk patients do on the pathway compared to 
the standard post-operative pathway?
– Can WARP be applied to all-risk patients undergoing PD 





– Can the WARP be expanded to 
WARP-eligible (WEPs) and WARP-
ineligible patients (WIPs) undergoing 
pancreaticoduodenectomy (PD) to 
improve the post-operative course?
• Hypothesis
– The WARP can be expanded to all 
patients undergoing PD, which 
results in lowered length of stay 
(LOS), post-operative complications 
(POC), time to adjuvant therapy 
(TTAT), and readmission rates (RR)
Approach & Results
• Study design 
– Single-institution, retrospective chart review
• Population / study sample
– 281 patients who underwent PD between 2017-2020
• 230 (81.9%) patients had malignant etiologies 
• 51 (18.1%) patients had benign etiologies 
• 119 (42.3%) were WARP-eligible under the initial criteria vs. 162 (57.7%) WARP-ineligible
• Intervention
– WARP (5 day pathway) in ALL patients  vs. Jefferson’s traditional 7 day pathway 
• Outcome 
– Primary endpoints: LOS, TTAT, RR, POC
• Data source and collection 
– Epic- retrospective chart review 
• Rationale for Approach 
– Jefferson is a major center for PD in the region
– Access to hundreds of patients in Epic that have undergone PD
Approach & Results 
• Analysis:
– Univariate/Multivariate analysis with logistic regression









28 (23.5%) 73 (45.1%) <0.05
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POCs: Delayed Gastric 
Emptying (DGE) & Post-
Op Pancreatic Fistulas 
(POPF) occurred in 
higher rates in WIPs 
(DGE: 10.2% vs. 26.2%, 




– WARP may be expanded to all-risk patients but
WIPs may benefit from some additional mitigation 
strategies to help lower RRs and POC while still 
minimizing LOS
– Ex: 
• WEPs- WARP is acceptable, target 4-5 day LOS
• WIPs- WARP-modification: target lower RR, lower POPF, 
lower DGE while minimizing LOS (5 days)
Future Directions
• Next Steps:
– Continue to analyze patients prospectively that 
are on the WARP pathway post-PD 
– Work to develop additional mitigation strategies
for WIPs to help lower POC, LOS, and RRs on the 
WARP pathway 
– Develop and pursue additional projects off of the 
established database
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